Flexion Therapeutics Inc.

Flexion Therapeutics develops musculoskeletal therapeutics, including ZILRETTA for knee OA, and advanced gene therapy FX201 and NaV1.7 inhibitor FX301 targeting pain, positioning it for growth within the specialty pharma market.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical Practices

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
FLXN	Flexion Therapeutics Inc.	EQUITY	NMS	USD	US33938J1060	Active	📈